Delivery Order SPE2DB20D3103-SPE2DB25FQ2R9
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $10,128.98 for Trulicity 0.75 mg/0.5 mL pens by the Defense Logistics Agency Medical Supply Chain. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025, and was competitively awarded without set-aside provisions. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Trulicity 1.5 mg/0.5 mL pens valued at $1,334.04. The contract employs firm fixed pricing with an ultimate completion date of August 11, 2025, and was awarded on August 8, 2025, without set-aside designation. This delivery order represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,500.88 by the Defense Logistics Agency (DLA) on July 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. This firm fixed-price delivery order is a non-set-aside contract with an ultimate completion date of July 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $4,944.66 by the Defense Logistics Agency (DLA) for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order awarded without any set-aside designation, reflecting a competitively awarded...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens valued at $1,226.40. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a single...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml) with a ceiling value of $1,041.84. This is a firm fixed price, non-competitive delivery order funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,669.96 by the Defense Logistics Agency on July 28, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens. The contract utilizes firm fixed pricing with no set-aside designation and is scheduled for completion by July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 23, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens with a ceiling value of $1,858.72. This competitive award, issued without a set-aside designation, carries a firm fixed price structure with an ultimate completion date of July 24, 2025. The product will be performed and distributed from the contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 20, 2025, for Trulicity 0.75 mg/0.5 ml pens valued at $4,850.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 21, 2025, and performance will occur at the vendor's Conshohocken facility. The award represents a child contract executed under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Trulicity 3 mg/0.5 mL pens valued at $1,553.26, with an ultimate completion date of July 31, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, to be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ2R9Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order valued at $5,405.40 by the Defense Logistics Agency on September 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. The contract carries a firm fixed price structure with an ultimate completion date of September 12, 2025, and utilizes no set-aside designation. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vehicle that extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. The award reflects AmerisourceBergen's established role as a critical pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Trulicity, a diabetes medication, represents one of many therapeutic categories supplied by the vendor through its expansive DLA contract portfolio, which encompasses specialty medications, brand-name and generic drugs, vaccines, and medical supplies. This delivery order exemplifies the company's capacity to fulfill federal medical supply requirements through open competition while maintaining the operational flexibility required to support worldwide military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/11/25 |